Stock Taper
EARNINGS CALL ARCHIVE 2 CALLS ON FILE
CPIX — Cumberland Pharmaceuticals Inc.
NASDAQ
FULL STOCK PAGE →

Q1 2026 Earnings Call Summary

MAY 6, 2026
REVENUE
$9.1M -33.2%
NET MARGIN
-34.4% -24.0 PTS
EPS
-$0.22 -133.1%
FREE CASH FLOW
$387025 +1048.2%

No summary has been written for this call yet.